abstract |
The invention relates to a physical form of the known glyburide drug substance, also known as glibenclamide and chemically defined as 5-chloro-N- [2- [4 - [[[cyclohexylamino) carbonyl] amino] sulfonyl] phenyl] -2-methoxybenzamide as well as dosage forms, e.g. tablets and capsules, including the physical form of the glyburide. |